Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns
- PMID: 577302
- DOI: 10.1203/00006450-197706000-00003
Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns
Abstract
Phosphatidylglycerol (PG) was absent from lung effluent in 41 infants with respiratory distress syndrome of the newborn (RDS), whereas effluent from healthy control subjects of similar gestational age contained this phospholipid (4.9 +/- 2.4% of lipidphosphorus (P), n = 32). Control infants of 28 weeks of gestation or less with various respiratory disturbances other than RDS also had low PG (0.2 +/- 0.2% of lipid-P, n = 5). In RDS surfactant complex often could be isolated from the airways using differential and density gradient centrifugation. The material thus obtained had prominent phosphatidylinositol (PI) (13.6 +/- 2.8% of lipid-P, n = 6), but no PG. Of those 18 infants who had such surfactant even in the early stages of RDS, 13 were 35 weeks of gestation or more, 3 were offspring of diabetic mothers, and 2 had severe perinatal asphyxia. In healthy control subjects PG sometimes appeared first within an hour of birth, but in RDS PG did not appear until recovery from RDS. In RDS type II (transient tachypnea of the newborn) PG in lung effluent also was abnormally low (1.3 +/- 0.6% of lipid-P, n = 5) and PI was correspondingly prominent (9.7 +/- 3.6% of lipid-P, n = 5), indicating immaturity of surfactant similar to RDS. Surfactant with PG and PI has superior surface-active properties compared to that containing PI, but no PG. Surfactant without PG does not seem to stabilize the alveoli of the newborn as well as does surfactant with PG. The failure of PG appearance following birth therefore may precipitate RDS, especially beyond 35 weeks of gestation.
Similar articles
-
Phospholipids in tracheal effluent from infants with severe respiratory distress syndrome.Am J Perinatol. 1984 Apr;1(3):208-13. doi: 10.1055/s-2007-1000006. Am J Perinatol. 1984. PMID: 6549258
-
[Tracheal phospholipid composition and respiratory distress syndrome of the newborn].Fortschr Med. 1979 Mar 8;97(9):403-8. Fortschr Med. 1979. PMID: 581867 German.
-
Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress.J Perinatol. 1992 Jun;12(2):129-33. J Perinatol. 1992. PMID: 1522430
-
Inherited disorders of neonatal lung diseases.Turk J Pediatr. 2004 Apr-Jun;46(2):105-14. Turk J Pediatr. 2004. PMID: 15214737 Review.
-
Chronic lung disease of the very low birth weight infant--is it preventable?Turk J Pediatr. 1998 Jan-Mar;40(1):35-44. Turk J Pediatr. 1998. PMID: 9673527 Review.
Cited by
-
Turnover of exogenous artificial surfactant.Arch Dis Child. 1992 Apr;67(4 Spec No):383-7. doi: 10.1136/adc.67.4_spec_no.383. Arch Dis Child. 1992. PMID: 1586175 Free PMC article. Clinical Trial.
-
Lecithin/sphingomyelin ratio from tracheal aspirates and compliance of the respiratory system in infants with bronchopulmonary dysplasia.Lung. 1990;168 Suppl:883-90. doi: 10.1007/BF02718224. Lung. 1990. PMID: 2117208
-
Lung surfactant.Environ Health Perspect. 1984 Apr;55:205-26. doi: 10.1289/ehp.8455205. Environ Health Perspect. 1984. PMID: 6145585 Free PMC article. Review.
-
Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.J Clin Invest. 1982 Sep;70(3):673-83. doi: 10.1172/jci110662. J Clin Invest. 1982. PMID: 6896715 Free PMC article.
-
Effects of Carboxyl or Amino Group Modified InP/ZnS Nanoparticles Toward Simulated Lung Surfactant Membrane.Front Bioeng Biotechnol. 2021 Aug 19;9:714922. doi: 10.3389/fbioe.2021.714922. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34490224 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous